John J. Alam, EVP, Medicines Development & CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 30,720 shares at $35.00 ($1.1M) on 2007-08-06, disclosed to the SEC on 2007-08-08.
Scheduled sale ($1.1M) by EVP, Medicines Development & CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CRVO | BUY | 2025-11-13 | $41K | — | Filing → |
| VRTX | SELL | 2008-10-02 | $139K | — | Filing → |
| VRTX | SELL | 2008-09-11 | $173K | — | Filing → |